Author： Hillson J.L. Furst D.E.
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.1, Iss.5, 2000-07, pp. : 1053-1066
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Drugs, Vol. 58, Iss. 3, 1999-09 ,pp. :
Access to resources
Recommend
Expert Opinion on Drug Safety, Vol. 4, Iss. 3, 2005-05 ,pp. :
Rofecoxib: Hepatitis: case report
Reactions Weekly, Vol. 1, Iss. 1069, 2005-01 ,pp. :
The "coadministration of rofecoxib and tizanidine is best avoided"
Reactions Weekly, Vol. 1, Iss. 1124, 2006-01 ,pp. :